SEC Form 4 · accession 0001651844-17-000006
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Jun 27, 2017
Accepted (ET)
Jun 29, 2017 · 5:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 27, 2017 | P | 2,500 | $4.14 | A | 3,040,050 | D | |
| Common Stock | Jun 27, 2017 | P | 500 | $4.15 | A | 3,040,550 | D | |
| Common Stock | Jun 27, 2017 | P | 2,000 | $4.16 | A | 3,042,550 | D | |
| Common Stock | Jun 28, 2017 | P | 500 | $4.00 | A | 3,043,050 | D | |
| Common Stock | Jun 28, 2017 | P | 1,000 | $4.01 | A | 3,044,050 | D | |
| Common Stock | Jun 28, 2017 | P | 2,000 | $4.02 | A | 3,046,050 | D | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.